CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
We are doing this study to learn more about how tirzepatide may help fight chronic kidney disease in people with obesity with or wi...
Phase 2
Indianapolis, Indiana, United States and 27 other locations
tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...
Phase 2, Phase 3
Indianapolis, Indiana, United States and 236 other locations
Primary Objective:Evaluate the effect of Hectorol® capsules in reducing elevated levels of intact parathyroid hormone (iPTH).Secondary Objectives:Eva...
Phase 3
Indianapolis, Indiana, United States and 29 other locations
evaluate the efficacy and safety of CIN-107 for the treatment of hypertension in patients with uncontrolled hypertension (uHTN) and Chronic Kidney...
Phase 2
Brownsburg, Indiana, United States and 70 other locations
This study is to evaluate the efficacy and safety of PLS240 in patients with hemodialysis-dependent end stage kidney disease (ESKD)...
Phase 3
Shelbyville, Indiana, United States and 67 other locations
dose ferric citrate versus placebo in patients with advanced chronic kidney disease (eGFR ≤20 ml/min/1.73m2) on the composite endpo...
Phase 3
Shelbyville, Indiana, United States and 22 other locations
The main purpose is to determine the safety of Triferic iron administered via dialysate and intravenously in pediatric patients with chronic kidney...
Phase 3
Indianapolis, Indiana, United States and 8 other locations
The purpose of this single-arm interventional study is to evaluate the long-term safety, efficacy, and durability of the Symplicity Spyral system in...
Indianapolis, Indiana, United States and 81 other locations
HAV and AVF groups over 12 months in patients with end-stage renal disease (ESRD) needing hemodialysis (HD).Participants will be stratified ...
Phase 3
Bloomington, Indiana, United States and 16 other locations
The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabete...
Phase 3
Avon, Indiana, United States and 390 other locations
Clinical trials
Research sites
Resources
Legal